Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 176

1.

Analysis of Pharmacovigilance Databases for Dolutegravir Safety in Pregnancy.

van De Ven NS, Pozniak AL, Levi JA, Clayden P, Garratt A, Redd C, Mofenson LM, Hill A.

Clin Infect Dis. 2019 Oct 9. pii: ciz684. doi: 10.1093/cid/ciz684. [Epub ahead of print]

PMID:
31595301
2.

Teashirt 1 (Tshz1) is essential for the development, survival and function of hypoglossal and phrenic motor neurons in mouse.

Chaimowicz C, Ruffault PL, Chéret C, Woehler A, Zampieri N, Fortin G, Garratt AN, Birchmeier C.

Development. 2019 Sep 6;146(17). pii: dev174045. doi: 10.1242/dev.174045.

3.

Postnatal Tshz3 Deletion Drives Altered Corticostriatal Function and Autism Spectrum Disorder-like Behavior.

Chabbert D, Caubit X, Roubertoux PL, Carlier M, Habermann B, Jacq B, Salin P, Metwaly M, Frahm C, Fatmi A, Garratt AN, Severac D, Dubois E, Kerkerian-Le Goff L, Fasano L, Gubellini P.

Biol Psychiatry. 2019 Aug 15;86(4):274-285. doi: 10.1016/j.biopsych.2019.03.974. Epub 2019 Mar 28.

4.

Measurement properties for the revised patient-reported OsteoArthritis Quality Indicator questionnaire.

Østerås N, Tveter AT, Garratt AM, Svinøy OE, Kjeken I, Natvig B, Grotle M, Hagen KB.

Osteoarthritis Cartilage. 2018 Oct;26(10):1300-1310. doi: 10.1016/j.joca.2018.06.007. Epub 2018 Jul 4.

5.

Evaluation of three patient reported outcome measures following operative fixation of closed ankle fractures.

Garratt AM, Naumann MG, Sigurdsen U, Utvåg SE, Stavem K.

BMC Musculoskelet Disord. 2018 May 2;19(1):134. doi: 10.1186/s12891-018-2051-5.

6.

Identification of Need for Psychiatric Help Among Asylum Seekers [Internet].

Gulbrandsen P, Garratt A, Linnestad K, Lie B, Sveaass N, Meyer M, Schanche I.

Oslo, Norway: Knowledge Centre for the Health Services at The Norwegian Institute of Public Health (NIPH); 2004.

7.

National and Cross-National Surveys of Patient Experiences: A Structured Review [Internet].

Garratt A, Solheim E, Danielsen K.

Oslo, Norway: Knowledge Centre for the Health Services at The Norwegian Institute of Public Health (NIPH); 2008 Feb.

8.

Loss of Intercalated Cells (ITCs) in the Mouse Amygdala of Tshz1 Mutants Correlates with Fear, Depression, and Social Interaction Phenotypes.

Kuerbitz J, Arnett M, Ehrman S, Williams MT, Vorhees CV, Fisher SE, Garratt AN, Muglia LJ, Waclaw RR, Campbell K.

J Neurosci. 2018 Jan 31;38(5):1160-1177. doi: 10.1523/JNEUROSCI.1412-17.2017. Epub 2017 Dec 18.

9.

Patient-reported outcomes after referral for possible valve replacement in patients with severe aortic stenosis.

Auensen A, Hussain AI, Garratt AM, Gullestad LL, Pettersen KI.

Eur J Cardiothorac Surg. 2018 Jan 1;53(1):129-135. doi: 10.1093/ejcts/ezx228.

PMID:
28977361
10.

Measurement properties and normative data for the Norwegian SF-36: results from a general population survey.

Garratt AM, Stavem K.

Health Qual Life Outcomes. 2017 Mar 14;15(1):51. doi: 10.1186/s12955-017-0625-9.

11.

The impact of psychological factors on condition-specific, generic and individualized patient reported outcomes in low back pain.

Løchting I, Garratt AM, Storheim K, Werner EL, Grotle M.

Health Qual Life Outcomes. 2017 Feb 21;15(1):40. doi: 10.1186/s12955-017-0593-0.

12.

The Universal Patient Centeredness Questionnaire: scaling approaches to reduce positive skew.

Bjertnaes O, Iversen HH, Garratt AM.

Patient Prefer Adherence. 2016 Nov 3;10:2255-2260. eCollection 2016.

13.

TSHZ3 deletion causes an autism syndrome and defects in cortical projection neurons.

Caubit X, Gubellini P, Andrieux J, Roubertoux PL, Metwaly M, Jacq B, Fatmi A, Had-Aissouni L, Kwan KY, Salin P, Carlier M, Liedén A, Rudd E, Shinawi M, Vincent-Delorme C, Cuisset JM, Lemaitre MP, Abderrehamane F, Duban B, Lemaitre JF, Woolf AS, Bockenhauer D, Severac D, Dubois E, Zhu Y, Sestan N, Garratt AN, Lydia Kerkerian-Le Goff, Fasano L.

Nat Genet. 2016 Nov;48(11):1359-1369. doi: 10.1038/ng.3681. Epub 2016 Sep 26.

14.

The Universal Patient Centeredness Questionnaire: reliability and validity of a one-page questionnaire following surveys in three patient populations.

Bjertnaes O, Iversen HH, Holmboe O, Danielsen K, Garratt A.

Patient Relat Outcome Meas. 2016 Jun 4;7:55-62. doi: 10.2147/PROM.S102732. eCollection 2016.

15.

Rasch analysis of the Norwegian version of the Arthritis Self-Efficacy Scale (ASES).

Garratt AM, Klokkerud M, Løchting I, Hagen KB.

Scand J Rheumatol. 2017 Jan;46(1):33-39. doi: 10.3109/03009742.2016.1155644. Epub 2016 May 17.

PMID:
27187620
16.

Eliciting Patient Risk Willingness in Clinical Consultations as a Means of Improving Decision-Making of Aortic Valve Replacement.

Hussain AI, Garratt AM, Brunborg C, Aakhus S, Gullestad L, Pettersen KI.

J Am Heart Assoc. 2016 Mar 18;5(3):e002828. doi: 10.1161/JAHA.115.002828.

17.

Neuregulin-1 controls an endogenous repair mechanism after spinal cord injury.

Bartus K, Galino J, James ND, Hernandez-Miranda LR, Dawes JM, Fricker FR, Garratt AN, McMahon SB, Ramer MS, Birchmeier C, Bennett DL, Bradbury EJ.

Brain. 2016 May;139(Pt 5):1394-416. doi: 10.1093/brain/aww039. Epub 2016 Mar 17.

18.

Validity of standard gamble utilities in patients referred for aortic valve replacement.

Hussain AI, Garratt AM, Beitnes JO, Gullestad L, Pettersen KI.

Qual Life Res. 2016 Jul;25(7):1703-12. doi: 10.1007/s11136-015-1186-1. Epub 2015 Nov 24.

PMID:
26603737
19.

Evaluation of the stages of completion and scoring of the Patient Generated Index (PGI) in patients with rheumatic diseases.

Garratt AM.

Qual Life Res. 2015 Nov;24(11):2625-35. doi: 10.1007/s11136-015-1014-7. Epub 2015 Jun 3.

PMID:
26038215
20.

Tshz1 Regulates Pancreatic β-Cell Maturation.

Raum JC, Soleimanpour SA, Groff DN, Coré N, Fasano L, Garratt AN, Dai C, Powers AC, Stoffers DA.

Diabetes. 2015 Aug;64(8):2905-14. doi: 10.2337/db14-1443. Epub 2015 Apr 27.

21.

Individualized quality of life in patients with low back pain: reliability and validity of the Patient Generated Index.

Løchting I, Grotle M, Storheim K, Werner EL, Garratt AM.

J Rehabil Med. 2014 Sep;46(8):781-7. doi: 10.2340/16501977-1826.

22.

Activation of MAPK overrides the termination of myelin growth and replaces Nrg1/ErbB3 signals during Schwann cell development and myelination.

Sheean ME, McShane E, Cheret C, Walcher J, Müller T, Wulf-Goldenberg A, Hoelper S, Garratt AN, Krüger M, Rajewsky K, Meijer D, Birchmeier W, Lewin GR, Selbach M, Birchmeier C.

Genes Dev. 2014 Feb 1;28(3):290-303. doi: 10.1101/gad.230045.113.

23.

TSHZ1-dependent gene regulation is essential for olfactory bulb development and olfaction.

Ragancokova D, Rocca E, Oonk AM, Schulz H, Rohde E, Bednarsch J, Feenstra I, Pennings RJ, Wende H, Garratt AN.

J Clin Invest. 2014 Mar;124(3):1214-27.

24.
25.

Measurement properties of instruments assessing self-efficacy in patients with rheumatic diseases.

Garratt AM, Løchting I, Smedslund G, Hagen KB.

Rheumatology (Oxford). 2014 Jul;53(7):1161-71. doi: 10.1093/rheumatology/ket374. Epub 2013 Nov 18. Review.

PMID:
24249031
26.

Wnt/Rspondin/β-catenin signals control axonal sorting and lineage progression in Schwann cell development.

Grigoryan T, Stein S, Qi J, Wende H, Garratt AN, Nave KA, Birchmeier C, Birchmeier W.

Proc Natl Acad Sci U S A. 2013 Nov 5;110(45):18174-9. doi: 10.1073/pnas.1310490110. Epub 2013 Oct 22.

27.

Which Roland-Morris Disability Questionnaire? Rasch analysis of four different versions tested in a Norwegian population.

Grotle M, Wilkens P, Garratt AM, Scheel I, Storheim K.

J Rehabil Med. 2013 Jul;45(7):670-7. doi: 10.2340/16501977-1166.

28.

Axonal neuregulin 1 is a rate limiting but not essential factor for nerve remyelination.

Fricker FR, Antunes-Martins A, Galino J, Paramsothy R, La Russa F, Perkins J, Goldberg R, Brelstaff J, Zhu N, McMahon SB, Orengo C, Garratt AN, Birchmeier C, Bennett DL.

Brain. 2013 Jul;136(Pt 7):2279-97. doi: 10.1093/brain/awt148.

29.

Bace1 and Neuregulin-1 cooperate to control formation and maintenance of muscle spindles.

Cheret C, Willem M, Fricker FR, Wende H, Wulf-Goldenberg A, Tahirovic S, Nave KA, Saftig P, Haass C, Garratt AN, Bennett DL, Birchmeier C.

EMBO J. 2013 Jul 17;32(14):2015-28. doi: 10.1038/emboj.2013.146. Epub 2013 Jun 21.

30.

Comparative responsiveness and minimal change of the Knee Quality of Life 26-item (KQoL-26) questionnaire.

Chuang LH, Garratt A, Brealey S.

Qual Life Res. 2013 Nov;22(9):2461-75. doi: 10.1007/s11136-012-0298-0. Epub 2013 Mar 7.

PMID:
23468169
31.

Patient-reported quality of care for osteoarthritis: development and testing of the osteoarthritis quality indicator questionnaire.

Østerås N, Garratt A, Grotle M, Natvig B, Kjeken I, Kvien TK, Hagen KB.

Arthritis Care Res (Hoboken). 2013 Jul;65(7):1043-51. doi: 10.1002/acr.21976.

32.

Wnt signaling in stem and cancer stem cells.

Holland JD, Klaus A, Garratt AN, Birchmeier W.

Curr Opin Cell Biol. 2013 Apr;25(2):254-64. doi: 10.1016/j.ceb.2013.01.004. Epub 2013 Jan 21. Review.

PMID:
23347562
33.

Psychometric properties of the Norwegian version of the patient generated index in patients with rheumatic diseases participating in rehabilitation or self-management programmes.

Klokkerud M, Grotle M, Løchting I, Kjeken I, Hagen KB, Garratt AM.

Rheumatology (Oxford). 2013 May;52(5):924-32. doi: 10.1093/rheumatology/kes401. Epub 2013 Jan 18.

PMID:
23335634
34.

Illness perceptions in patients receiving rheumatology rehabilitation: association with health and outcomes at 12 months.

Løchting I, Fjerstad E, Garratt AM.

BMC Musculoskelet Disord. 2013 Jan 16;14:28. doi: 10.1186/1471-2474-14-28.

35.

Patients with well-established ankylosing spondylitis show limited deterioration in a ten-year prospective cohort study.

Healey EL, Haywood KL, Jordan KP, Garratt AM, Packham JC.

Clin Rheumatol. 2013 Jan;32(1):67-72. doi: 10.1007/s10067-012-2092-3. Epub 2012 Sep 27.

PMID:
23015228
36.

Current practice and barriers to the management of sexual issues in rheumatology: results of a survey of health professionals.

Helland Y, Garratt A, Kjeken I, Kvien TK, Dagfinrud H.

Scand J Rheumatol. 2013;42(1):20-6. doi: 10.3109/03009742.2012.709274. Epub 2012 Sep 21.

PMID:
22994142
37.

The Nordic Patient Experiences Questionnaire (NORPEQ): cross-national comparison of data quality, internal consistency and validity in four Nordic countries.

Skudal KE, Garratt AM, Eriksson B, Leinonen T, Simonsen J, Bjertnaes OA.

BMJ Open. 2012 May 30;2(3). pii: e000864. doi: 10.1136/bmjopen-2012-000864. Print 2012.

38.

BACE1 dependent neuregulin processing: review.

Fleck D, Garratt AN, Haass C, Willem M.

Curr Alzheimer Res. 2012 Feb;9(2):178-83. Review.

PMID:
22455478
39.

Development of the Rheumatic Disease Illness Perception Questionnaire (RD-IPQ) reliability, validity and responsiveness.

Løchting I, Garratt AM, Klokkerud M, Fjerstad E.

Clin Exp Rheumatol. 2012 Mar-Apr;30(2):308. Epub 2012 Apr 13. No abstract available.

PMID:
22325016
40.

Evaluation of Ankylosing Spondylitis Quality of Life questionnaire: responsiveness of a new patient-reported outcome measure.

Packham JC, Jordan KP, Haywood KL, Garratt AM, Healey EL.

Rheumatology (Oxford). 2012 Apr;51(4):707-14. doi: 10.1093/rheumatology/ker377. Epub 2011 Dec 16.

PMID:
22179735
41.

Reliability and construct validity of self-report questionnaires for patients with pelvic girdle pain.

Grotle M, Garratt AM, Krogstad Jenssen H, Stuge B.

Phys Ther. 2012 Jan;92(1):111-23. doi: 10.2522/ptj.20110076. Epub 2011 Oct 20.

PMID:
22016375
42.

The ability of a behaviour-specific patient questionnaire to identify poorly performing doctors.

Fossli Jensen B, Dahl FA, Safran DG, Garratt AM, Krupat E, Finset A, Gulbrandsen P.

BMJ Qual Saf. 2011 Oct;20(10):885-93. doi: 10.1136/bmjqs-2011-000021. Epub 2011 Aug 17.

PMID:
21849336
43.

BACE1 Dependent Neuregulin Proteolysis.

Fleck D, Garratt AN, Haass C, Willem M.

Curr Alzheimer Res. 2011 May 23. [Epub ahead of print]

PMID:
21605034
44.

Parent experiences questionnaire for outpatient child and adolescent mental health services (PEQ-CAMHS Outpatients): reliability and validity following a national survey.

Garratt AM, Bjertnaes OA, Holmboe O, Hanssen-Bauer K.

Child Adolesc Psychiatry Ment Health. 2011 May 21;5:18. doi: 10.1186/1753-2000-5-18.

45.

The pelvic girdle questionnaire: a condition-specific instrument for assessing activity limitations and symptoms in people with pelvic girdle pain.

Stuge B, Garratt A, Krogstad Jenssen H, Grotle M.

Phys Ther. 2011 Jul;91(7):1096-108. doi: 10.2522/ptj.20100357. Epub 2011 May 19.

PMID:
21596959
46.

Evaluation of a modified arthritis self-efficacy scale for an ankylosing spondylitis UK population.

Sandhu J, Packham JC, Healey EL, Jordan KP, Garratt AM, Haywood KL.

Clin Exp Rheumatol. 2011 Mar-Apr;29(2):223-30. Epub 2011 Apr 19.

PMID:
21504660
47.

The AUSCAN subscales, AIMS-2 hand/finger subscale, and FIOHA were not unidimensional scales.

Haugen IK, Moe RH, Slatkowsky-Christensen B, Kvien TK, van der Heijde D, Garratt A.

J Clin Epidemiol. 2011 Sep;64(9):1039-46. doi: 10.1016/j.jclinepi.2010.11.013. Epub 2011 Mar 16.

PMID:
21411282
48.

Axonally derived neuregulin-1 is required for remyelination and regeneration after nerve injury in adulthood.

Fricker FR, Lago N, Balarajah S, Tsantoulas C, Tanna S, Zhu N, Fageiry SK, Jenkins M, Garratt AN, Birchmeier C, Bennett DL.

J Neurosci. 2011 Mar 2;31(9):3225-33. doi: 10.1523/JNEUROSCI.2568-10.2011.

49.

Identification of shoulder-specific patient acceptable symptom state in patients with rheumatic diseases undergoing shoulder surgery.

Christie A, Dagfinrud H, Garratt AM, Ringen Osnes H, Hagen KB.

J Hand Ther. 2011 Jan-Mar;24(1):53-60; quiz 61. doi: 10.1016/j.jht.2010.10.006.

PMID:
21272764
50.

Participants' preference for type of leaflet used to feed back the results of a randomised trial: a survey.

Brealey S, Andronis L, Dennis L, Atwell C, Bryan S, Coulton S, Cox H, Cross B, Fylan F, Garratt A, Gilbert F, Gillan M, Hendry M, Hood K, Houston H, King D, Morton V, Robling M, Russell I, Wilkinson C.

Trials. 2010 Dec 1;11:116. doi: 10.1186/1745-6215-11-116.

Supplemental Content

Loading ...
Support Center